Literature DB >> 32033146

Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Kirti S Prabhu1, Afsheen Raza2, Thasni Karedath3, Syed Shadab Raza4, Hamna Fathima1, Eiman I Ahmed1, Shilpa Kuttikrishnan1,5, Lubna Therachiyil1,5, Michal Kulinski1, Said Dermime2, Kulsoom Junejo6, Martin Steinhoff1,7,8,9, Shahab Uddin1.   

Abstract

Breast cancer is regarded as a heterogeneous and complicated disease that remains the prime focus in the domain of public health concern. Next-generation sequencing technologies provided a new perspective dimension to non-coding RNAs, which were initially considered to be transcriptional noise or a product generated from erroneous transcription. Even though understanding of biological and molecular functions of noncoding RNA remains enigmatic, researchers have established the pivotal role of these RNAs in governing a plethora of biological phenomena that includes cancer-associated cellular processes such as proliferation, invasion, migration, apoptosis, and stemness. In addition to this, the transmission of microRNAs and long non-coding RNAs was identified as a source of communication to breast cancer cells either locally or systemically. The present review provides in-depth information with an aim at discovering the fundamental potential of non-coding RNAs, by providing knowledge of biogenesis and functional roles of micro RNA and long non-coding RNAs in breast cancer and breast cancer stem cells, as either oncogenic drivers or tumor suppressors. Furthermore, non-coding RNAs and their potential role as diagnostic and therapeutic moieties have also been summarized.

Entities:  

Keywords:  biogenesis; breast cancer stem cells; long non-coding RNA; microRNA; targets

Year:  2020        PMID: 32033146      PMCID: PMC7072613          DOI: 10.3390/cancers12020351

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  265 in total

1.  CCL2 mediates cross-talk between cancer cells and stromal fibroblasts that regulates breast cancer stem cells.

Authors:  Akihiro Tsuyada; Amy Chow; Jun Wu; George Somlo; Peiguo Chu; Sofia Loera; Thehang Luu; Arthur Xuejun Li; Xiwei Wu; Wei Ye; Shiuan Chen; Weiying Zhou; Yang Yu; Yuan-Zhong Wang; Xiubao Ren; Hui Li; Peggy Scherle; Yukio Kuroki; Shizhen Emily Wang
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

3.  lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.

Authors:  Gabriel Eades; Benjamin Wolfson; Yongshu Zhang; Qinglin Li; Yuan Yao; Qun Zhou
Journal:  Mol Cancer Res       Date:  2014-09-24       Impact factor: 5.852

4.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.

Authors:  Li Ma; Julie Teruya-Feldstein; Robert A Weinberg
Journal:  Nature       Date:  2007-09-26       Impact factor: 49.962

Review 5.  RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts.

Authors:  Sarah Geisler; Jeff Coller
Journal:  Nat Rev Mol Cell Biol       Date:  2013-10-09       Impact factor: 94.444

6.  Induction of miRNA-181a by genotoxic treatments promotes chemotherapeutic resistance and metastasis in breast cancer.

Authors:  Jixiao Niu; Aimin Xue; Yayun Chi; Jingyan Xue; Wei Wang; Ziqin Zhao; Meiyun Fan; Chuan He Yang; Zhi-Ming Shao; Lawrence M Pfeffer; Jiong Wu; Zhao-Hui Wu
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

Review 7.  The hedgehog pathway in triple-negative breast cancer.

Authors:  Joyce G Habib; Joyce A O'Shaughnessy
Journal:  Cancer Med       Date:  2016-08-18       Impact factor: 4.452

8.  NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells.

Authors:  Ying Zhong; Songjie Shen; Yidong Zhou; Feng Mao; Yan Lin; Jinghong Guan; Yali Xu; Shu Zhang; Xu Liu; Qiang Sun
Journal:  Onco Targets Ther       Date:  2016-11-07       Impact factor: 4.147

Review 9.  Long Non-Coding RNA and Breast Cancer.

Authors:  Tianzhu Zhang; Hui Hu; Ge Yan; Tangwei Wu; Shuiyi Liu; Weiqun Chen; Yong Ning; Zhongxin Lu
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

10.  MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.

Authors:  Qian Jiang; Miao He; Meng-Tao Ma; Hui-Zhe Wu; Zhao-Jin Yu; Shu Guan; Long-Yang Jiang; Yan Wang; Da-Di Zheng; Feng Jin; Min-Jie Wei
Journal:  Oncol Rep       Date:  2015-12-21       Impact factor: 3.906

View more
  11 in total

Review 1.  Cancer stem cells: a major culprit of intra-tumor heterogeneity.

Authors:  Faiza Naz; Mengran Shi; Salvia Sajid; Zhao Yang; Changyuan Yu
Journal:  Am J Cancer Res       Date:  2021-12-15       Impact factor: 6.166

2.  Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer.

Authors:  Lianghao Zhang; Longqing Li; Yonghao Zhan; Jiange Wang; Zhaowei Zhu; Xuepei Zhang
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

Review 3.  Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease.

Authors:  Amal Qattan
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

4.  LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining β-Catenin in the Nucleus to Augment Wnt Signaling.

Authors:  Liang Peng; Rong Ye; Xiansen Zhu; Yuankang Xie; Baiyin Zhong; Yao Liu; Heping Li; Binhui Xie
Journal:  Biomed Res Int       Date:  2022-01-28       Impact factor: 3.411

5.  LOC102724163 promotes breast cancer cell proliferation and invasion by stimulating MUC19 expression.

Authors:  Tao Jiang; Zhong-Bing Luo
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967

6.  Variation of Long Non-Coding RNA And mRNA Profiles in Breast Cancer Cells With Influences of Adipocytes.

Authors:  Xin-Hui Cao; Kai Yang; Ming-Xing Liang; Pei Ma; Di Xu; Yin-Jiao Fei; Wei Zhang; Xiu Chen; Jin-Hai Tang
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

Review 7.  Long noncoding RNAs in osteosarcoma via various signaling pathways.

Authors:  Jinming Han; Xiaohan Shen
Journal:  J Clin Lab Anal       Date:  2020-04-06       Impact factor: 2.352

8.  LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway.

Authors:  Yang Li; Hong-Yu Ma; Xiao-Wei Hu; Yuan-Yuan Qu; Xin Wen; Yu Zhang; Qing-Yong Xu
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

9.  ZNRD1-AS1 Promotes Nasopharyngeal Carcinoma Cell Invasion and Metastasis by Regulating the miR-335-ROCK1 Axis.

Authors:  Qiang Wang; Xinyu Hu; Mingyu Du; Zhiwei Lu; Keshi Yan; Dingliang Zhao; Ning Jiang; Yi Peng; Xia He; Li Yin
Journal:  Onco Targets Ther       Date:  2020-05-27       Impact factor: 4.147

10.  MAFA-AS1, a long non-coding RNA, predicts for poor survival of hepatocellular carcinoma.

Authors:  Yuting Zhan; Xin-Yuan Guan; Yan Li
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.